Role and Function of O-GlcNAcylation in Cancer
Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or incre...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6e8bd2548de24ebea13a9ecd381bb1cf |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6e8bd2548de24ebea13a9ecd381bb1cf |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6e8bd2548de24ebea13a9ecd381bb1cf2021-11-11T15:29:08ZRole and Function of O-GlcNAcylation in Cancer10.3390/cancers132153652072-6694https://doaj.org/article/6e8bd2548de24ebea13a9ecd381bb1cf2021-10-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/21/5365https://doaj.org/toc/2072-6694Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or increase in cellular stress results in the proliferation, progression, and metastasis of cancer cells. Notably, cancer is one of the emerging diseases associated with O-GlcNAcylation. In this review, we summarize studies that delineate the role of O-GlcNAcylation in cancer, including its modulation in metastasis, function with receptor tyrosine kinases, and resistance to chemotherapeutic agents, such as cisplatin. In addition, we discuss the function of O-GlcNAcylation in eliciting immune responses associated with immune surveillance in the tumor microenvironment. O-GlcNAcylation is increasingly accepted as one of the key players involved in the activation and differentiation of T cells and macrophages. Finally, we discuss the prognostic role of O-GlcNAcylation and potential therapeutic agents such as O-linked β-N-acetylglucosamine-transferase inhibitors, which may help overcome the resistance mechanism associated with the reprogramming of glucose metabolism.Jii Bum LeeKyoung-Ho PyoHye Ryun KimMDPI AGarticleO-GlcNAcylationO-GlcNAc transferaseO-GlcNAcasecellular stresscancerimmune surveillanceNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5365, p 5365 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
O-GlcNAcylation O-GlcNAc transferase O-GlcNAcase cellular stress cancer immune surveillance Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
O-GlcNAcylation O-GlcNAc transferase O-GlcNAcase cellular stress cancer immune surveillance Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Jii Bum Lee Kyoung-Ho Pyo Hye Ryun Kim Role and Function of O-GlcNAcylation in Cancer |
description |
Cancer cells are able to reprogram their glucose metabolism and retain energy via glycolysis even under aerobic conditions. They activate the hexosamine biosynthetic pathway (HBP), and the complex interplay of O-linked N-acetylglucosaminylation (O-GlcNAcylation) via deprivation of nutrients or increase in cellular stress results in the proliferation, progression, and metastasis of cancer cells. Notably, cancer is one of the emerging diseases associated with O-GlcNAcylation. In this review, we summarize studies that delineate the role of O-GlcNAcylation in cancer, including its modulation in metastasis, function with receptor tyrosine kinases, and resistance to chemotherapeutic agents, such as cisplatin. In addition, we discuss the function of O-GlcNAcylation in eliciting immune responses associated with immune surveillance in the tumor microenvironment. O-GlcNAcylation is increasingly accepted as one of the key players involved in the activation and differentiation of T cells and macrophages. Finally, we discuss the prognostic role of O-GlcNAcylation and potential therapeutic agents such as O-linked β-N-acetylglucosamine-transferase inhibitors, which may help overcome the resistance mechanism associated with the reprogramming of glucose metabolism. |
format |
article |
author |
Jii Bum Lee Kyoung-Ho Pyo Hye Ryun Kim |
author_facet |
Jii Bum Lee Kyoung-Ho Pyo Hye Ryun Kim |
author_sort |
Jii Bum Lee |
title |
Role and Function of O-GlcNAcylation in Cancer |
title_short |
Role and Function of O-GlcNAcylation in Cancer |
title_full |
Role and Function of O-GlcNAcylation in Cancer |
title_fullStr |
Role and Function of O-GlcNAcylation in Cancer |
title_full_unstemmed |
Role and Function of O-GlcNAcylation in Cancer |
title_sort |
role and function of o-glcnacylation in cancer |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/6e8bd2548de24ebea13a9ecd381bb1cf |
work_keys_str_mv |
AT jiibumlee roleandfunctionofoglcnacylationincancer AT kyounghopyo roleandfunctionofoglcnacylationincancer AT hyeryunkim roleandfunctionofoglcnacylationincancer |
_version_ |
1718435243730403328 |